Preserving the intellectual output & resources of the University of Missouri.
Stroke prevention: Age alone does not rule out warfarin
MOspace/Manakin Repository
Breadcrumbs Navigation
Stroke prevention: Age alone does not rule out warfarin
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/5406
| Title: | Stroke prevention: Age alone does not rule out warfarin |
| Author: | Schumann, Sarah-Anne; Ewigman, Bernard |
| Keywords: |
cardiovascular prevention
hemorrhage risk anticoagulant |
| Date: | 2007-11 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | Journal of Family Practice, 56(11) 2007: 902-906. |
| Abstract: | Warfarin is as safe as aspirin and more effective for stroke prevention in elders with atrial fibrillation. Strength of recommendation (SOR) A: Well-designed randomized controlled trial of elderly patients in the primary care setting, consistent with findings from prior RCTs. |
| URI: | http://hdl.handle.net/10355/5406 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Priority Updates to Research Literature (PURLs) [87]
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.